Shares of Maidenform Brands Inc. rose 14.2 percent to $24.90 Tuesday after the innerwear apparel maker said first-quarter profits doubled, due in part to strong gains in its shapewear business. The firm also raised its guidance above Wall Street’s estimates.
This story first appeared in the May 12, 2010 issue of WWD. Subscribe Today.
The Iselin, N.J.-based company said that, for the three months ended April 3, net income hit $12.1 million, or 51 cents a diluted share, compared with $6 million, or 26 cents, in the year-ago period. Sales rose 25.1 percent to $142.9 million, from $114.2 million a year earlier. Wholesale sales increased 27.4 percent to $131.6 million, from $103.3 million, while retail sales rose 3.7 percent to $11.3 million from $10.9 million.
Top- and bottom-line results exceeded analysts’ expectations for earnings per share of 40 cents on revenue of $133.9 million.
Leaner inventories and reduced promotional activity drove the firm’s gross margin up to 36.3 percent of sales versus 32 percent a year earlier.
Within the wholesale segment, Maidenform said the department store sector registered a 32.3 percent gain in revenue, to $57.3 million, while sales to mass merchants increased 14.9 percent to $45.4 million. Other revenues advanced 41 percent to $28.9 million.
Shapewear sales, up 34 percent, were key to the quarter’s performance.
“Shapewear now makes up more than a third of Maidenform’s global business and is the fastest-growing category in intimate apparel,” said chief executive officer Maurice Reznik on the company call. “Importantly, it is also our fastest-growing segment and highest-margin contributor.”
He expects the category’s momentum, represented by a 14 percent compound annual growth rate, to continue.
The firm projected second-quarter EPS to be between 45 cents and 50 cents, with sales growing in the low- to mid-20 percent range from the year-ago level of $114.2 million. Analysts were looking for second-quarter earnings of 37 cents on sales of $125.8 million.
Maidenform shares hit a new 52-week high of $25.31 in intraday trading.